Abstract | BACKGROUND: Newborns and young infants are at higher risk for infections than adults, and manifest suboptimal vaccine responses, motivating a search for novel immunomodulators and/or vaccine adjuvants effective in early life. In contrast to most TLR agonists (TLRA), TLR8 agonists such as imidazoquinolines (IMQs) induce adult-level Th1-polarizing cytokine production from human neonatal cord blood monocytes and are candidate early life adjuvants. We assessed whether TLR8-activating IMQ congeners may differ in potency and efficacy in inducing neonatal cytokine production in vitro, comparing the novel TLR7/8-activating IMQ analogues Hybrid-2, Meta- amine, and Para- amine to the benchmark IMQ resiquimod (R848). METHODS: TLRA-induced NF-κB activation was measured in TLR-transfected HEK cells. Cytokine production in human newborn cord and adult peripheral blood and in monocyte-derived dendritic cell cultures were measured by ELISA and multiplex assays. X-ray crystallography characterized the interaction of human TLR8 with Hybrid-2. RESULTS: Hybrid-2 selectively activated both TLR7 and 8 and was more potent than R848 in inducing adult-like levels of TNF-α, and IL-1β. Consistent with its relatively high in vitro activity, crystallographic studies suggest that absence in Hybrid-2 of an ether oxygen of the C2-ethoxymethyl substituent, which can engage in unfavorable electrostatic and/or dipolar interactions with the carbonyl oxygen of Gly572 in human TLR8, may confer greater efficacy and potency compared to R848. CONCLUSIONS: Hybrid-2 is a selective and potent TLR7/8 agonist that is a candidate adjuvant for early life immunization.
|
Authors | Lakshmi Ganapathi, Simon Van Haren, David J Dowling, Ilana Bergelson, Nikunj M Shukla, Subbalakshmi S Malladi, Rajalakshmi Balakrishna, Hiromi Tanji, Umeharu Ohto, Toshiyuki Shimizu, Sunil A David, Ofer Levy |
Journal | PloS one
(PLoS One)
Vol. 10
Issue 8
Pg. e0134640
( 2015)
ISSN: 1932-6203 [Electronic] United States |
PMID | 26274907
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cytokines
- Imidazoles
- Immunosuppressive Agents
- Quinolines
- Recombinant Fusion Proteins
- Toll-Like Receptor 7
- Toll-Like Receptor 8
- resiquimod
|
Topics |
- Adult
- Cytokines
(metabolism)
- Dendritic Cells
(drug effects, metabolism)
- Female
- Fetal Blood
(cytology, drug effects, metabolism)
- HEK293 Cells
- Humans
- Imidazoles
(pharmacology)
- Immunosuppressive Agents
(pharmacology)
- Infant, Newborn
- Leukocytes
(drug effects, metabolism)
- Pregnancy
- Quinolines
(pharmacology)
- Recombinant Fusion Proteins
(pharmacology)
- Toll-Like Receptor 7
(agonists)
- Toll-Like Receptor 8
(agonists)
- Up-Regulation
(drug effects)
|